275
Views
0
CrossRef citations to date
0
Altmetric
Review

Novel insights into central compartment atopic disease - a literature review

, ORCID Icon, , &
Pages 847-856 | Received 14 Dec 2022, Accepted 14 Mar 2023, Published online: 21 Mar 2023

References

  • Grayson JW, Hopkins C, Mori E, et al. Contemporary classification of chronic rhinosinusitis beyond polyps vs no polyps: a review. JAMA Otolaryngol Head Neck Surg. 2020;146(9):831–838. DOI:10.1001/jamaoto.2020.1453
  • Lee K, Kim TH, Lee SH, et al. Predictive value of radiologic central compartment atopic disease for identifying allergy and asthma in pediatric patients. Ear Nose Throat J. 2021;145561321997546(9):593–599.
  • Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(1):1–464.
  • Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11(3):213–739.
  • Marcus S, DelGaudio JM, Roland LT, et al. Chronic rhinosinusitis: does allergy play a role? Med Sci (Basel). 2019;7(2):30.
  • Haque R, White AA, Jackson DJ, et al. Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2021;148(2):283–291.
  • DelGaudio JM, Loftus PA, Hamizan AW, et al. Central compartment atopic disease. Am J Rhinol Allergy. 2017;31(4):228–234.
  • Bent JP 3rd, Kuhn FA. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg. 1994;111(5):580–588.
  • White LJ, Rotella MR, DelGaudio JM. Polypoid changes of the middle turbinate as an indicator of atopic disease. Int Forum Allergy Rhinol. 2014;4(5):376–380.
  • Hamizan AW, Christensen JM, Ebenzer J, et al. Middle turbinate edema as a diagnostic marker of inhalant allergy. Int Forum Allergy Rhinol. 2017;7(1):37–42.
  • Xu X, Reitsma S, Wang Y, et al. Updates in biologic therapy for chronic rhinosinusitis with nasal polyps and NSAID-exacerbated respiratory disease. Allergy. 2022;77(12):3593–3605.
  • Lee SH, Han MS, Lee TH, et al. Rhinovirus-induced anti-viral interferon secretion is not deficient and not delayed in sinonasal epithelial cells of patients with chronic rhinosinusitis with nasal polyp. Front Immunol. 2022;13:1025796.
  • Bachert C, Han JK, Wagenmann M, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management. J Allergy Clin Immunol. 2021;147(1):29–36.
  • Sedaghat AR, Phillips KM. Keeping our eyes on the prize: personalized and precision medicine with biologics for chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2022;10(7):1887–1888.
  • Bachert C, Marple B, Schlosser RJ, et al. Adult chronic rhinosinusitis. Nat Rev Dis Primers. 2020;6(1):86.
  • Schleimer RP. Immunopathogenesis of chronic rhinosinusitis and nasal polyposis. Annu Rev Pathol. 2017;12(1):331–357.
  • Fujieda S, Imoto Y, Kato Y, et al. Eosinophilic chronic rhinosinusitis. Allergol Int. 2019;68(4):403–412.
  • Yao Y, Zeng M, Liu Z. Revisiting Asian chronic rhinosinusitis in the era of type 2 biologics. Clin Exp Allergy. 2022;52(2):231–243.
  • Wang X, Sima Y, Zhao Y, et al. Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factors. J Allergy Clin Immunol. 2023;151(2):458–468.
  • Zhang Y, Gevaert E, Lou H, et al. Chronic rhinosinusitis in Asia. J Allergy Clin Immunol. 2017;140(5):1230–1239.
  • Katotomichelakis M, Tantilipikorn P, Holtappels G, et al. Inflammatory patterns in upper airway disease in the same geographical area may change over time. Am J Rhinol Allergy. 2013;27(5):354–360.
  • Kong W, Wu Q, Chen Y, et al. Chinese central compartment atopic disease: the clinical characteristics and cellular endotypes based on whole-slide imaging. J Asthma Allergy. 2022;15:341–352.
  • Nie Z, Xu Z, Fan Y, et al. Clinical characteristics of central compartment atopic disease in Southern China. Int Forum Allergy Rhinol. 2022;13(3):205–215.
  • Lin YT, Lin CF, Liao CK, et al. Clinical characteristics and cytokine profiles of central-compartment-type chronic rhinosinusitis. Int Forum Allergy Rhinol. 2021;11(7):1064–1073.
  • Chen W, Bai Y, Kong W, et al. Predictive significance of Charcot-Leyden crystal structures for nasal polyp recurrence. Clin Transl Allergy. 2022;12(11):e12212.
  • Jonstam K, Swanson BN, Mannent LP, et al. Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis. Allergy. 2019;74:743–752.
  • Lou H, Meng Y, Piao Y, et al. Cellular phenotyping of chronic rhinosinusitis with nasal polyps. Rhinology. 2016;54(2):150–159.
  • Steehler AJ, Vuncannon JR, Wise SK, et al. Central compartment atopic disease: outcomes compared with other subtypes of chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2021;11(11):1549–1556.
  • Grayson JW, Cavada M, Harvey RJ. Clinically relevant phenotypes in chronic rhinosinusitis. J Otolaryngol Head Neck Surg. 2019;48(1):23.
  • Glenis K, Scadding VJL. Investigative rhinology. London: CRC Press; 2004.
  • Hamizan AW, Loftus PA, Alvarado R, et al. Allergic phenotype of chronic rhinosinusitis based on radiologic pattern of disease. Laryngoscope. 2018;128(9):2015–2021.
  • Roland LT, Marcus S, Schertzer JS, et al. Computed tomography findings can help identify different chronic rhinosinusitis with nasal polyp phenotypes. Am J Rhinol Allergy. 2020;34(5):679–685.
  • Marcus S, Schertzer J, Roland LT, et al. Central compartment atopic disease: prevalence of allergy and asthma compared with other subtypes of chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2020;10(2):183–189.
  • DelGaudio JM, Levy JM, Wise SK. Central compartment involvement in aspirin-exacerbated respiratory disease: the role of allergy and previous sinus surgery. Int Forum Allergy Rhinol. 2019;9(9):1017–1022.
  • Schertzer JS, Levy JM, Wise SK, et al. Is respiratory epithelial adenomatoid hamartoma related to central compartment atopic disease? Am J Rhinol Allergy. 2020;34(5):610–617.
  • Bergmark RW, Palumbo M, Rahman S, et al. Aspirin-exacerbated respiratory disease: association between patient-reported sinus and asthma morbidity. J Allergy Clin Immunol Pract. 2021;9(4):1604–1611.
  • Dominas C, Gadkaree S, Maxfield AZ, et al. Aspirin-exacerbated respiratory disease: a review. Laryngoscope Investig Otolaryngol. 2020;5(3):360–367.
  • Kennedy JL, Stoner AN, Borish L. Aspirin-exacerbated respiratory disease: prevalence, diagnosis, treatment, and considerations for the future. Am J Rhinol Allergy. 2016;30(6):407–413.
  • Philpott CM, Thamboo A, Lai L, et al. Olfactory dysfunction in allergic fungal rhinosinusitis. Arch Otolaryngol Head Neck Surg. 2011;137(7):694–697.
  • Makary CA, Falco J, Sussman S, et al. Disease involvement in the central compartment in eosinophilic chronic rhinosinusitis. Int Forum Allergy Rhinol. 2021;11(10):1417–1423.
  • Safi C, Li C, Tabaee A, et al. Outcomes and imaging findings of respiratory epithelial adenomatoid hamartoma: a systematic review. Int Forum Allergy Rhinol. 2019;9(6):674–680.
  • Fitzhugh VA, Mirani N. Respiratory epithelial adenomatoid hamartoma: a review. Head Neck Pathol. 2008;2(3):203–208.
  • Schemel AF, Zamperini KM, Soderlund KA, et al. Respiratory epithelial adenomatoid hamartoma. Head Neck Pathol. 2023. DOI:10.1007/s12105-022-01519-5
  • Cho SH, Hamilos DL, Han DH, et al. Phenotypes of chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2020;8(5):1505–1511.
  • Laidlaw TM, Mullol J, Fan C, et al. Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD. J Allergy Clin Immunol Pract. 2019;7(7):2462–5 e1.
  • White AA, Woessner K, Simon R. Aspirin-exacerbated respiratory disease: update on medical management. World J Otorhinolaryngol Head Neck Surg. 2020;6(4):241–247.
  • Benjamin MR, Stevens WW, Li N, et al. Clinical characteristics of patients with chronic rhinosinusitis without nasal polyps in an academic setting. J Allergy Clin Immunol Pract. 2019;7(3):1010–1016.
  • Khan A, Vandeplas G, Huynh TMT, et al. The Global Allergy and Asthma European Network (GALEN rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps). Rhinology. 2019;57(1):32–42.
  • Ho J, Alvarado R, Rimmer J, et al. Atopy in chronic rhinosinusitis: impact on quality of life outcomes. Int Forum Allergy Rhinol. 2019;9(5):501–507.
  • Tan BK, Zirkle W, Chandra RK, et al. Atopic profile of patients failing medical therapy for chronic rhinosinusitis. Int Forum Allergy Rhinol. 2011;1(2):88–94. DOI:10.1002/alr.20025
  • Brunner JP, Jawad BA, McCoul ED. Polypoid change of the middle turbinate and paranasal sinus polyposis are distinct entities. Otolaryngol Head Neck Surg. 2017;157(3):519–523.
  • Abdullah B, Vengathajalam S, Md Daud MK, et al. The clinical and radiological characterizations of the allergic phenotype of chronic rhinosinusitis with nasal polyps. J Asthma Allergy. 2020;13:523–531.
  • Edwards TS, DelGaudio JM, Levy JM, et al. A prospective analysis of systemic and local aeroallergen sensitivity in central compartment atopic disease. Otolaryngol Head Neck Surg. 2022;167(5):885–890.
  • Tripathi SH, Ungerer HN, Rullan-Oliver B, et al. Similarities between allergen sensitivity patterns of central compartment atopic disease and allergic rhinitis. Int Forum Allergy Rhinol. 2022;12:1299–1302.
  • Shih LC, Hsieh BH, Ma JH, et al. A comparison of central compartment atopic disease and lateral dominant nasal polyps. Int Forum Allergy Rhinol. 2022;12:1387–1396.
  • Chandra RK. In reply: central compartment atopic disease: the missing link in the allergy and CRSwNP saga. Int Forum Allergy Rhinol. 2020;10:1193–1194.
  • Zhang Y, Zhang LY, Huang F, et al. Computational investigation of Artemisia pollen deposition in realistic nasal cavities of residents in northwest China. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019;54:741–747.
  • Wang W, Huang X, Chen Z, et al. Prevalence and trends of sensitisation to aeroallergens in patients with allergic rhinitis in Guangzhou, China: a 10-year retrospective study. BMJ Open. 2016;6:e011085.
  • Gevaert P, Nouri-Aria KT, Wu H, et al. Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polyps. Allergy. 2013;68:55–63.
  • Bachert C, Zhang N. Chronic rhinosinusitis and asthma: novel understanding of the role of IgE ‘above atopy’. J Intern Med. 2012;272:133–143.
  • DelGaudio JM. Central compartment atopic disease: the missing link in the allergy and chronic rhinosinusitis with nasal polyps saga. Int Forum Allergy Rhinol. 2020;10:1191–1192.
  • Philpott C, Hopkins C, Erskine S, et al. The burden of revision sinonasal surgery in the UK-data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study. BMJ Open. 2015;5:e006680.
  • Li N, Peters AT. Chronic rhinosinusitis management beyond intranasal steroids and saline solution irrigations. Allergy Asthma Proc. 2015;36:339–343.
  • Bachert C, Zhang N, Cavaliere C, et al. Biologics for chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2020;145:725–739.
  • Geng B, Dilley M, Anterasian C. Biologic therapies for allergic rhinitis and nasal polyposis. Curr Allergy Asthma Rep. 2021;21:36.
  • Bachert C, Han JK, Desrosiers MY, et al. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2022;149:1309–17 e12.
  • Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394:1638–1650.
  • Han JK, Bachert C, Fokkens W, et al. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021;9:1141–1153.
  • Eckl-Dorna J, Villazala-Merino S, Campion NJ, et al. Tracing IgE-producing cells in allergic patients. Cells. 2019;8:994.
  • Lupinek C, Derfler K, Lee S, et al. Extracorporeal IgE immunoadsorption in allergic asthma: safety and efficacy. EBioMedicine. 2017;17:119–133.
  • Ceballos Cantu JC, Alobid I, Mullol J. Current evaluation and management of patients with chronic rhinosinusitis and nasal polyps. Expert Rev Clin Immunol. 2022;18:1253–1263.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.